PRRT2 and breast carcinoma: Evaluation of the specific PKC isozymes soon followed and PKCα (8–14), PKCβ (as discussed below), PKCδ (15, 16), PKCε (17), and PKCη (18, 19) were all found to have roles in breast cancer progression.